News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rawcliffe Adrian
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $4.58, valued at
$206.1k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 13,042 shares
@ $1.7468, valued at
$22.8k
Sold 18,763 shares
@ $1.706, valued at
$32k
|
|
| 01/04/2023 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 5,073 shares
@ $1.694, valued at
$8.6k
|
|
| 09/01/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 2,536 shares
@ $1.9689, valued at
$5k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/27/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 2,562 shares
@ $1.63, valued at
$4.2k
|
|
| 01/18/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 11,096 shares
@ $3.1918, valued at
$35.4k
|
|
| 01/13/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 14,362 shares
@ $3.5567, valued at
$51.1k
Sold 3,046 shares
@ $3.5441, valued at
$10.8k
|
|
| 01/13/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 4,690,224 options to buy
@ $0
Granted 1,047,480 options to buy
@ $0 |
|
| 01/05/2022 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 5,532 shares
@ $4.0642, valued at
$22.5k
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 42,000 options to buy
@ $5.97, valued at
$250.7k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2020 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 2,776 shares
@ $8.5149, valued at
$23.6k
|
|
| 08/20/2020 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 10,500 options to buy
@ $9.13, valued at
$95.9k
|
|
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 2,515,536 options to buy
@ $0
Granted 561,792 options to buy
@ $0 |
|
| 01/15/2020 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,236 shares
@ $5.1347, valued at
$16.6k
|
|
| 01/07/2020 |
4
| Rawcliffe Adrian (CEO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 5,900 shares
@ $1.2, valued at
$7.1k
|
|
| 09/03/2019 |
4
| Rawcliffe Adrian (CEO and CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 628,872 options to buy
@ $0
Granted 140,448 options to buy
@ $0 |
|
| 08/16/2019 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 10,500 options to buy
@ $20.34, valued at
$213.6k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/16/2019 |
4
| Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 3,084 shares
@ $5.3694, valued at
$16.6k
|
|
| 01/08/2019 |
4
| Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,257,744 options to buy
@ $0
Granted 280,896 options to buy
@ $0 |
|
| 08/15/2018 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 9,000 options to buy
@ $46.7, valued at
$420.3k
|
|
| 03/22/2018 |
4
| Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 600,000 shares
@ $1.71, valued at
$1M
|
|
| 01/17/2018 |
4
| Rawcliffe Adrian (CFO) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 687,984 options to buy
@ $0
Granted 153,648 options to buy
@ $0 |
|
| 08/17/2017 |
4
| Rawcliffe Adrian (Director) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 9,000 options to buy
@ $18.1, valued at
$162.9k
|
|
|
|
|